Upregulation of the Bcl-2 family of proteins in end stage heart failure

Journal of the American College of Cardiology

Volumn 35, Issue 7, 2000, Pages 1769-1777

  Latif, Najma ^a   Khan, Mahboob A ^a   Birks, Emma ^a   O'Farrell, Aldo ^a   Westbrook, Jules ^a   Dunn, Michael J ^a   Yacoub, Magdi H ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DILATATION; HEART FAILURE; HEART VENTRICLE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; ISCHEMIC HEART DISEASE; MALE; NICK END LABELING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; WESTERN BLOTTING;

ADULT; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 0034075609     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00647-1     Document Type: Article

References (50)

1. Bardales R.H., Hailey L.S., Xie S.S., Schaefer R.F., Hsu S.-M. In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Path. 149:1996;821-829.
2. Itoh G., Tamura J., Suzuki M., et al. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labelling method and DNA agarose gel electrophoresis. Am J Path. 146:1995;1325-1331.
3. Misao J., Hayakawa Y., Ohno M., Kato S., Fujiwara T., Fujiwara H. Expression of Bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 94:1996;1506-1512.
4. Saraste A., Pulkki K., Kallajoki M., Henriksen K., Parvinen M., Voipio-Pulkki L.-M. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
5. Mallat L., Tedgui A., Fontaliran F., Frank R., Durigon M., Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasis. N Engl J Med. 334:1996;1190-1196.
6. James N., St. Martin E., Willis P.W. III, Lohr T.O. Apoptosis as a possible cause of gradual development of complate heart block and fatal arrhythmias associated with absence of the AV node, the sinus node and the internodal pathways. Circulation. 93:1996;1424-1438.
7. James T.N., Froggatt P., Atkinson W.J. Jr, Lurie P.R., McNamara D.G. De Subitaneis Mortibus. XXX. Observations on the pathophysiology of the long QT syndromes with special reference to the neuropathology of the heart. Circulation. 57:1978;1221-1231.
8. James T.N. Long reflections on the QT interval the Sixth Annual Gordon K. Moe Lecture . J Cardiovasc Electrophysiol. 7:1996;738-759.
9. James T.N., Nichols M.M., Sapire D.W., DiPatre P.L., Lopez S.M. Complete heart block and fatal right ventricular failure in an infant. Circulation. 93:1996;1588-1600.
10. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 95:1995;2266-2274.
11. Isner J.M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
12. Olivetti G., Abi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
13. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
14. Ino T., Nishimoto K., Okubo M., et al. Apoptosis as a possible cause of wall thinning in end-stage hypertrophic cardiomyopathy. Am J Cardiol. 79:1997;1137-1141.
15. Tsujimoto Y., Gorham J., Cossman J., Jaffe E., Croce C.M. The t (14:18) chromosomal translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science. 229:1985;1390-1393.
16. Cleary M.L., Sklar J. Nucleotide sequence of a t (14:18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA. 82:1985;7439-7443.
17. Boise L.H., Gonzalez-Garcia M., Postema C.E., et al. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
18. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
19. Chittenden T., Harrington E.A., O'Connor R., et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736.
20. Keifer M.C., Brauer M.J., Powers V.C., et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:1995;736-739.
21. Farrow S.N., White J.H.N., Martinou I., et al. Cloning of a Bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:1995;731-733.
22. Oltvai Z.N., Korsmeyer S.J. Checkpoints of dueling dimers foil death wishes. Cell. 79:1994;189-192.
23. Sato T., Hanada M., Bodrud S., et al. Interactions among members of the Bcl-2 family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA. 91:1994;9238-9242.
24. L and Bcl-2 displaces Bax and promotes cell death . Cell. 80:1995;285-291.
25. Bodrug S.E., Aime-Sempe C., Sato T., Krajewski S., Hanada M., Reed J.C. Biochemical and functional comparisons of mcl-1 and Bcl-2 proteins evidence for a novel mechanism of regulating Bcl-2 family protein function . Cell Death Differ. 2:1995;173-182.
26. Kanoh M., Takemura G., Misao J., et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy not apoptosis but DNA repair . Circulation. 99:1999;2757-2764.
27. th ed. Philadelphia: WB Saunders, 1997:394-420.
28. Tanaka M., Ito H., Adachhi S., et al. Hypoxia induces apoptosis with enhanced expression of fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
29. Long X., Boluyt M.O., Hipolito M.L., et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest. 99:1997;2635-2643.
30. Feuerstein G., Poste G., Ruffolo R.R. Jr. Carvedilol update III rationale for use in congestive heart failure . Drug Today. 31:1995;307-326.
31. Communal C., Singh K., Pimentel D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation. 98:1998;1329-1334.
32. James T.N. Normal and abnormal consequences of apoptosis in the human heart from postnatal morphogenesis to paroxysmal arrhythmias . Circulation. 90:1994;556-573.
33. Bordron A., Dueymes M., Levy Y., et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest. 101:1998;2029-2035.
34. Nakamura N., Ban T., Yamaji K., Yoneda Y., Wada Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding subset. J Clin Invest. 101:1998;1951-1959.
35. L forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.
36. Schendel S.L., Xie Z., Montal M.O., Matsuyama S., Montal M., Reed J.C. Channel formation by antiapoptotic protein, Bcl-2. Proc Natl Acad Sci USA. 94:1997;5113-5118.
37. Antonsson B., Conti F., Ciavatta A.M., et al. Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:1997;370-372.
38. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
39. Wu D., Wallen H.D., Nunez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science. 275:1997;1126-1129.
40. Chinnaiyan A.M., O'Rourke K., Lane B.R., Dixit V.M. Interaction of CED-4 with CED-3 and CED-9 a molecular framework for cell death . Science. 275:1997;1122-1126.
41. Petit P.X., Susin S.A., Zamzami N., Mignotte B., Kroemer G. Mitochondria and programmed cell death back to the future . FEBS Lett. 396:1996;7-13.
42. L function upstream of the CED3-like apoptotic proteases. J Biol Chem. 271:1996;4573-4576.
43. Shimizu S., Eguchi Y., Kamiike W., Matsuda H., Tsujimoto Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene. 12:1996;2251-2257.
44. Boulakia C.A., Chen G., Ng F.W.H., et al. Bcl-2 and adenovirus E1B 19-kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly (ADP-ribose) polymerase. Oncogene. 12:1996;529-535.
45. Zamzami N., Marchetti P., Castedo M., et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 181:1995;1661-1672.
46. Shimizu S., Eguchi Y., Kamiike W., et al. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene. 13:1996;21-29.
47. Yang J., Liu X., Bhalla K., et al. Prevention of apoptosis by Bcl-2 - release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
48. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria a primary sit for Bcl-2 regulation of apoptosis . Science. 275:1997;1132-1136.
49. Narula J., Pandey P., Arbustini E., et al. Apoptosis in heart failure release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy . Proc Natl Acad Sci USA. 96:1999;8144-8149.
50. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 399:1999;483-487.